Treatment with ramipril improves systolic function even in patients with mild systolic dysfunction and symptoms of heart failure after acute myocardial infarctionShow others and affiliations
1998 (English)In: Clinical Cardiology, ISSN 0160-9289, E-ISSN 1932-8737, Vol. 21, no 11, p. 807-811Article in journal (Refereed) Published
Abstract [en]
Background: Clinical signs of heart failure such as pulmonary rales and dyspnea, ventricular dysfunction, and ventricular arrhythmia are independent predictors of a poor prognosis after acute myocardial infarction (AMI).
Hypothesis: The study aimed to assess the effect of ramipril treatment on mildly depressed left ventricular (LV) systolic function, assessed by atrioventricular (AV) plane displacement in patients with congestive heart failure after AMI.
Methods: The study was a substudy in the Acute Infarction Ramipril Efficacy Study, a double-blind, randomized, placebo-controlled trial of ramipril versus placebo in patients with symptoms of heart failure after AMI. In all, 56 patients were included in the main study, 4 refused to participate in the substudy, and 4 were excluded for logistical reasons. Echocardiography was performed at entry and after 6 months. Patients who underwent coronary artery bypass grafting during the follow-up period were excluded.
Results: At baseline, the patients had modest LV dysfunction, and mean AV plane displacement of 9.7 mm. During follow-up, AV plane displacement increased in ramipril-treated patients from 9.5 to 10.9 mm (p<0.01). No statistically significant changes were seen in the placebo group.
Conclusions: Ramipril improves LV systolic function in patients with clinical signs of heart failure and only modest systolic dysfunction after AMI. Measurement of AV plane displacement is a simple and reproducible method for detection of small changes in systolic function and may be used instead of ejection fraction in patients with poor image quality.
Place, publisher, year, edition, pages
John Wiley & Sons, 1998. Vol. 21, no 11, p. 807-811
Keywords [en]
Heart failure, Left ventricular systolic function, Myocardial infarction, Ramipril, captopril, dipeptidyl carboxypeptidase inhibitor, placebo, acute heart infarction, adult, aged, article, clinical trial, controlled clinical trial, controlled study, double blind procedure, drug effect, drug efficacy, echocardiography, enzyme inhibition, female, heart left ventricle contraction, heart left ventricle function, human, image quality, major clinical study, male, randomized controlled trial, reproducibility, systole
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:hj:diva-63329DOI: 10.1002/clc.4960211105ISI: 000076944800004PubMedID: 9825192Scopus ID: 2-s2.0-0031759493OAI: oai:DiVA.org:hj-63329DiVA, id: diva2:1827063
2024-01-122024-01-122025-02-10Bibliographically approved